↓ Skip to main content

A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification

Overview of attention for article published in BMC Cancer, February 2016
Altmetric Badge

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification
Published in
BMC Cancer, February 2016
DOI 10.1186/s12885-016-2124-5
Pubmed ID
Authors

Line S. Tarpgaard, Camilla Qvortrup, Sune B. Nygård, Signe L. Nielsen, Diana R. Andersen, Niels Frank Jensen, Jan Stenvang, Sönke Detlefsen, Nils Brünner, Per Pfeiffer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 13%
Researcher 5 11%
Student > Ph. D. Student 5 11%
Student > Master 4 9%
Professor 3 7%
Other 7 15%
Unknown 16 35%
Readers by discipline Count As %
Medicine and Dentistry 14 30%
Biochemistry, Genetics and Molecular Biology 3 7%
Nursing and Health Professions 3 7%
Agricultural and Biological Sciences 2 4%
Business, Management and Accounting 1 2%
Other 3 7%
Unknown 20 43%